Results for tag: "Veltassa"

Veltassa is a drug used to treat hyperkalemia, a condition characterized by elevated levels of potassium in the blood. It is used in the treatment of liver and kidney disorders, such as chronic kidney disease, cirrhosis, and end-stage renal disease. Veltassa works by binding to potassium in the gastrointestinal tract, preventing it from being absorbed into the bloodstream. It is available in both oral and intravenous formulations. The Veltassa market is composed of pharmaceutical companies that manufacture and distribute the drug. These companies are involved in research and development, manufacturing, marketing, and distribution of the drug. They also provide support services such as patient education and counseling. Some companies in the Veltassa market include Relypsa, Inc., AstraZeneca, and Daiichi Sankyo. Show Less Read more